Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes

Obesity

Volumn 18, Issue 9, 2010, Pages 1781-1787

  Utzschneider, Kristina M ^a,b   Van De Lagemaat, Anne ^a,b   Faulenbach, Mirjam V ^a,b   Goedecke, Julia H ^c   Carr, Darcy B ^b   Boyko, Edward J ^a   Fujimoto, Wilfred Y ^a   Kahn, Steven E ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; BODY MASS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; WAIST CIRCUMFERENCE;

ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; ROC CURVE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 77956094588     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.77     Document Type: Article

References (31)

1. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J. Effect of obesity oninsulin resistance in normal subjects and patients with NIDDM. Diabetes1995;44:1121-1125.
2. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolicallyhealthy but obese individuals (MHO)? Diabetes Metab 2004;30:569-572.
3. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome,and risk of type 2 diabetes or cardiovascular disease. J Clin EndocrinolMetab 2006;91:2906-2912.
4. Ferrannini E, Natali A, Bell P et al. Insulin resistance and hypersecretionin obesity. European Group for the Study of Insulin Resistance (EGIR).J Clin Invest 1997;100:1166-1173.
5. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normalweightAmericans: new definition of the metabolically obese, normal-weightindividual. Diabetes Care 2004;27:2222-2228.
6. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolicsyndrome as predictor of type 2 diabetes: the San Antonio heart study.Diabetes Care 2003;26:3153-3159.
7. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortalityassociated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
8. Dekker JM, Girman C, Rhodes T et al. Metabolic syndrome and 10-yearcardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-673.
9. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome andtotal and cardiovascular disease mortality in middle-aged men. JAMA2002;288:2709-2716.
10. Reaven GM. Banting lecture 1988. Role of insulin resistance in humandisease. Diabetes 1988;37:1595-1607.
11. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management ofthe metabolic syndrome: an American Heart Association/National Heart,Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
12. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-widedefinition. A Consensus Statement from the International DiabetesFederation. Diabet Med 2006;23:469-480.
13. Després JP, Lemieux I, Bergeron J et al. Abdominal obesity and themetabolic syndrome: contribution to global cardiometabolic risk. ArteriosclerThromb Vasc Biol 2008;28:1039-1049.
14. Raffel LJ, Robbins DC, Norris JM et al. The GENNID Study. A resource formapping the genes that cause NIDDM. Diabetes Care 1996;19:864-872.
15. Hayashi T, Boyko EJ, McNeely MJ et al. Minimum waist and visceralfat values for identifying Japanese Americans at risk for the metabolicsyndrome. Diabetes Care 2007;30:120-127.
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis modelassessment: insulin resistance and beta-cell function from fasting plasmaglucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
17. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oralglucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care 1999;22:1462-1470.
18. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference,and health risk: evidence in support of current National Institutes of Healthguidelines. Arch Intern Med 2002;162:2074-2079.
19. Edelstein SL, Knowler WC, Bain RP et al. Predictors of progression fromimpaired glucose tolerance to NIDDM: an analysis of six prospective studies.Diabetes 1997;46:701-710.
20. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effectsof physical activity, body mass index, waist circumference and waist-to-hipratio with the risk of cardiovascular disease among middle-aged Finnish menand women. Eur Heart J 2004;25:2212-2219.
21. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity andrisk of coronary heart disease in men. Int J Obes Relat Metab Disord2001;25:1047- 1056.
22. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity andcoronary heart disease in women. JAMA 1998;280:1843-1848.
23. Cameron AJ, Boyko EJ, Sicree RA et al. Central obesity as a precursorto the metabolic syndrome in the AusDiab study and Mauritius. Obesity(Silver Spring) 2008;16:2707-2716.
24. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importanceof waist circumference in the definition of metabolic syndrome: prospectiveanalyses of mortality in men. Diabetes Care 2006;29:404-409.
25. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolicsyndrome: mechanisms mediating risk for metabolic and cardiovasculardisease. Curr Opin Lipidol 2007;18:263-270.
26. Vilarrasa N, Vendrell J, Maravall J et al. Distribution and determinants ofadiponectin, resistin and ghrelin in a randomly selected healthy population.Clin Endocrinol (Oxf) 2005;63:329-335.
27. Wildman RP, Muntner P, Reynolds K et al. The obese withoutcardiometabolic risk factor clustering and the normal weight withcardiometabolic risk factor clustering: prevalence and correlates of 2phenotypes among the US population (NHANES 1999-2004). Arch InternMed 2008;168:1617-1624.
28. Bonora E, Kiechl S, Willeit J et al. Prevalence of insulin resistance inmetabolic disorders: the Bruneck Study. Diabetes 1998;47:1643-1649.
29. Executive Summary: Standards of Medical Care in Diabetes-2008.Diabetes Care 2008;31(Suppl 1):S5-S11.
30. Bobo N, Evert A, Gallivan J et al. An update on type 2 diabetes in youth fromthe National Diabetes Education Program. Pediatrics 2004;114:259-263.
31. Ardern CI, Janssen I, Ross R, Katzmarzyk PT. Development of healthrelatedwaist circumference thresholds within BMI categories. Obes Res2004;12:1094-1103.